Identification of candidate anti-cancer molecular mechanisms of Compound Kushen Injection using functional genomics

Compound Kushen Injection (CKI) has been clinically used in China for over 15 years to treat various types of solid tumours. However, because such Traditional Chinese Medicine (TCM) preparations are complex mixtures of plant secondary metabolites, it is essential to explore their underlying molecula...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Qu, Zhipeng, Cui, Jian, Harata-Lee, Yuka, Aung, Thazin Nwe, Feng, Qianjin, Raison, Joy M., Kortschak, Robert Daniel, Adelson, David L.
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2016
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5323210/
https://ncbi.nlm.nih.gov/pubmed/27602759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11788
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares